NMS-03592088

· Nerviano Medical Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NMS-03592088, covering 2026-03-18 to 2026-03-18. Get the full timeline:

Most recent: Clinical Trial Update: Study of NMS-03592088 in Patients With Relapsed or Refractory AML or CMML [Phase 1, Phase 2]